ACE2 and COVID-19: Since most organs, such as the lungs, hearts, and kidneys, compromised in COVID-19 patients are also enriched with ACE2, blocking the overexpression of ACE2 in these organs could serve as a novel therapeutic target in effectively treating COVID-19.